RSC Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
16(3), P. 1141 - 1150
Published: Dec. 23, 2024
High-throughput
chemistry
(HTC)
and
direct-to-biology
(D2B)
platforms
allow
for
plate-based
compound
synthesis
biological
evaluation
of
crude
mixtures
in
cellular
assays.
Frontiers in Genetics,
Journal Year:
2024,
Volume and Issue:
15
Published: July 31, 2024
Cancer
continues
to
present
a
substantial
global
health
challenge,
with
its
incidence
and
mortality
rates
persistently
reflecting
significant
impact.
The
emergence
of
precision
oncology
has
provided
breakthrough
in
targeting
oncogenic
drivers
previously
deemed
“undruggable”
by
conventional
therapeutics
limiting
off-target
cytotoxicity.
Two
groundbreaking
technologies
that
have
revolutionized
the
field
are
primarily
CRISPR-Cas9
gene
editing
more
recently
PROTAC
(PROteolysis
TArgeting
Chimeras)
targeted
protein
degradation
technology.
CRISPR-Cas9,
particular,
gained
widespread
recognition
acclaim
due
remarkable
ability
modify
DNA
sequences
precisely.
Rather
than
genetic
code,
PROTACs
harness
ubiquitin
proteasome
machinery
degrade
proteins
interest
selectively.
Even
though
operate
on
different
principles,
they
share
common
goal
advancing
whereby
both
approaches
demonstrated
potential
preclinical
promising
data
clinical
trials.
this
genes
directly
indirectly
precise,
efficient,
reversible,
adaptable,
tissue-specific
manner,
as
diagnostic
tool.
On
other
hand,
administer
low
doses
orally,
broad
targeting,
tissue
specificity,
controllability
reinforced
PROTAC.
Thus,
oncology,
using
CRISPR
technology
interventions,
while
further
expanded
therapeutic
landscape
enabling
selective
degradation.
viewing
them
mutually
exclusive
or
competing
methods
their
use
is
context-dependent
(i.e.,
based
molecular
mechanisms
disease)
potentially
could
be
used
synergistically
complementing
strengths
vice
versa
.
Herein,
we
review
current
status
designs
implications
terms
potential,
trial
data,
limitations,
compare
oncology.
ACS Medicinal Chemistry Letters,
Journal Year:
2024,
Volume and Issue:
15(10), P. 1787 - 1794
Published: Sept. 12, 2024
The
science
of
drug
discovery
involves
multiparameter
optimization
molecular
structures
through
iterative
design-make-test
cycles.
For
medicinal
chemistry
library
synthesis,
traditional
workflows
involve
the
isolation
each
individual
compound,
gravimetric
quantitation,
and
preparation
a
standard
concentration
solution
for
biological
assays.
In
this
work,
we
explore
ways
to
expedite
process
by
testing
unpurified
mixtures
using
combination
mass
spectrometry-based
assays
affinity
selection
microsomal
metabolic
stability.
Utilizing
approach,
microgram
quantities
crude
can
be
used
identify
high
affinity,
metabolically
stable
members
full
characterization.
This
streamlined
approach
was
demonstrated
synthesis
evaluation
two
libraries
histone
deacetylase
inhibitors
shown
generate
decision-making
data
in
line
with
workflows.
advantages
paradigm
include
greatly
reduced
cycle
time,
material
requirements,
resources
on
most
promising
compounds.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 18, 2024
SUMMARY
Self-labeling
protein
tags
are
an
efficient
means
to
visualize,
manipulate,
and
isolate
engineered
fusion
proteins
with
suitable
chemical
probes.
The
SNAP-tag,
which
covalently
conjugates
benzyl-guanine
-chloropyrimidine
derivatives
is
used
extensively
in
fluorescence
microscopy,
given
the
availability
of
SNAP-ligand-based
Here,
we
extend
applicability
SNAP-tag
targeted
degradation.
We
developed
a
set
SNAP
PROteolysis
TArgeting
Chimeras
(SNAP-PROTACs),
recruit
VHL
or
CRBN-ubiquitin
E3
ligases
induce
degradation
SNAP-fusion
proteins.
Endogenous
tagging
enabled
visualization
selective
depletion
SNAP-clathrin
light
chain
using
SNAP-PROTACs.
addition
PROTACs
reagent
toolbox
facilitates
comprehensive
analysis
function
single
gene
event.
RSC Chemical Biology,
Journal Year:
2024,
Volume and Issue:
5(12), P. 1232 - 1247
Published: Jan. 1, 2024
Extending
the
applications
of
SNAP-tag:
VHL-
and
CRBN-recruiting
SNAP-PROTACs
provide
a
ready-to-use
targeted
protein
degradation
system
for
SNAP-fusion
proteins.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 1, 2024
Abstract
Proteolysis
targeting
chimeras
(PROTACs)
are
bifunctional
small
molecules
that
recruit
an
E3
ligase
to
a
target
protein,
leading
ubiquitin
transfer
and
subsequent
proteasomal
degradation.
The
formation
of
ternary
complexes
is
crucial
step
in
PROTAC-induced
protein
degradation,
gaining
structural
insights
essential
for
rational
PROTAC
design.
In
this
study,
we
present
novel
approach
efficiently
sampling
complexes,
which
has
been
validated
using
40
co-crystallized
complex
structures.
comparison
protein-protein
docking-based
integrative
approaches,
our
method
achieved
impressive
success
rate
97%
50%
retrospectively,
measured
by
C
α
-RMSD
the
crystal
structure
within
10
4
Å,
respectively,
with
average
CPU
time
hours.
Notably,
utilizing
unbound
structures,
values
between
predicted
experimental
structures
were
consistently
7
Å
across
six
WDR5-PROTAC-VHL
Our
open-source
software
enables
modeling
single
holds
promise
enhancing
design
efforts.
TOC
RSC Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
16(3), P. 1141 - 1150
Published: Dec. 23, 2024
High-throughput
chemistry
(HTC)
and
direct-to-biology
(D2B)
platforms
allow
for
plate-based
compound
synthesis
biological
evaluation
of
crude
mixtures
in
cellular
assays.